Login Register Cart 0
Recent Advances in Food, Nutrition & Agriculture

Recent Advances in Food, Nutrition & Agriculture

Editor-in-Chief

ISSN (Print): 2772-574X
ISSN (Online): 2772-5758

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

Therapeutic Potential of Quercetin Analogues: Prospective and Advances

Author(s): Harsh Yadav, Rishabha Malviya*orcid of author, Niranjan Kaushik and Sathvik Belagodu Sridhar

Volume 17, Issue 1, 2026

Published on: 07 November, 2024

Page: [33 - 41] Pages: 9

DOI: 10.2174/012772574X332803240930065210

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

The purpose of the article is to investigate the therapeutic potential of quercetin and related compounds by elucidating their pharmacological characteristics and molecular mechanisms of action. The potential benefits of quercetin and its analogs for cardiovascular health, disorders of the brain, metabolic disorders, and more are discussed in the discussion part of this article. Concerns about their clinical efficacy due to issues with bioavailability and distribution are also discussed. This section of the paper emphasizes the importance of researchers and clinicians working together to maximize the incorporation of these chemicals into real-world therapeutic approaches. In conclusion, quercetin, along with related substances, shows great potential in a wide range of therapeutic settings. Potentially useful for the management of a wide variety of illnesses, their multiple methods of action include the regulation of pathways for cell signaling and interaction with different enzymes. However, additional clinical trials are needed to verify their efficacy and safety.

Keywords: Quercetin, cardiovascular health, therapeutic applications, natural flavonoid, bioactive polyphenol, molecular mechanisms of action.

« Previous Next »

Graphical Abstract

Graphical abstract illustrating key findings of the study

[1]
Crozier A, Del Rio D, Clifford MN. Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 2010; 31(6): 446-67.
[http://dx.doi.org/10.1016/j.mam.2010.09.007]
[2]
Malviya R. Ankit, Sharma A. Sources, properties, and pharmacological effects of quercetin. Curr Nutr Food Sci 2022; 18(5): 457-65.
[http://dx.doi.org/10.2174/1573401318666220127140859]
[3]
Hollman PC, Katan MB. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother 1997; 51(8): 305-10.
[4]
Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005; 45(4): 287-306.
[http://dx.doi.org/10.1080/1040869059096] [PMID: 16047496]
[5]
Cushnie TPT, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents 2005; 26(5): 343-56.
[http://dx.doi.org/10.1016/j.ijantimicag.2005.09.002] [PMID: 16323269]
[6]
Li Y, Yao J, Han C, et al. Quercetin, inflammation and immunity. Nutrients 2016; 8(3): 167.
[http://dx.doi.org/10.3390/nu8030167] [PMID: 26999194]
[7]
Carullo G, Cappello AR, Frattaruolo L, Badolato M, Armentano B, Aiello F. Quercetin and derivatives: Useful tools in inflammation and pain management. Future Med Chem 2017; 9(1): 79-93.
[http://dx.doi.org/10.4155/fmc-2016-0186]
[8]
Murota K, Terao J. Antioxidative flavonoid quercetin: Implication of its intestinal absorption and metabolism. Arch Biochem Biophys 2003; 417(1): 12-7.
[http://dx.doi.org/10.1016/S0003-9861(03)00284-4] [PMID: 12921774]
[9]
Yao LH, Jiang YM, Shi J, et al. Flavonoids in food and their health benefits. Plant Foods Hum Nutr 2004; 59(3): 113-22.
[http://dx.doi.org/10.1007/s11130-004-0049-7] [PMID: 15678717]
[10]
Walle T. Bioavailability of resveratrol. Ann N Y Acad Sci 2011; 1215(1): 9-15.
[http://dx.doi.org/10.1111/j.1749-6632.2010.05842.x] [PMID: 21261636]
[11]
Cushnie TP, Lamb AJ. Recent advances in understanding the antibacterial properties of flavonoids. Int J Antimicrob Agents 2016; 48(5): 421-30.
[PMID: 21514796]
[12]
Fischer C, Speth V, Fleig-Eberenz S, Neuhaus G. Induction of zygotic polyembryos in wheat: Influence of auxin polar transport. Plant Cell 1997; 9(10): 1767-80.
[http://dx.doi.org/10.2307/3870523] [PMID: 12237347]
[13]
McKillop K, Harnly J, Pehrsson P, Fukagawa N, Finley J. Fooddata central, USDA’s updated approach to food composition data systems. Curr Dev Nutr 2021; 5: 596.
[http://dx.doi.org/10.1093/cdn/nzab044_027]
[14]
Rhodes DG, Morton S, Myrowitz R, Moshfegh AJ. Food and nutrient database for dietary studies 2019–2020: An application database for national dietary surveillance. J Food Compos Anal 2023; 123: 105547.
[http://dx.doi.org/10.1016/j.jfca.2023.105547]
[15]
Lee KA, Kim KT, Kim HJ, et al. Antioxidant activities of onion (Allium cepa L.) peel extracts produced by ethanol, hot water, and subcritical water extraction. Food Sci Biotechnol 2014; 23(2): 615-21.
[http://dx.doi.org/10.1007/s10068-014-0084-6]
[16]
Wang SY, Chen CT, Sciarappa W, Wang CY, Camp MJ. Fruit quality, antioxidant capacity, and flavonoid content of organically and conventionally grown blueberries. J Agric Food Chem 2008; 56(14): 5788-94.
[http://dx.doi.org/10.1021/jf703775r] [PMID: 18590274]
[17]
Ortuño A, Reynaldo I, Fuster MD, et al. Citrus cultivars with high flavonoid contents in the fruits. Sci Hortic (Amsterdam) 1997; 68(1-4): 231-6.
[http://dx.doi.org/10.1016/S0304-4238(96)00988-0]
[18]
Chu YH, Chang CL, Hsu HF. Flavonoid content of several vegetables and their antioxidant activity. J Sci Food Agric 2000; 80(5): 561-6.
[19]
Crozier A, Lean MEJ, McDonald MS, Black C. Quantitative analysis of the flavonoid content of commercial tomatoes, onions, lettuce, and celery. J Agric Food Chem 1997; 45(3): 590-5.
[http://dx.doi.org/10.1021/jf960339y]
[20]
Du B, He BJ, Shi PB, Li FY, Li J, Zhu FM. Phenolic content and antioxidant activity of wine grapes and table grapes. J Med Plants Res 2012; 6(17): 3381-7.
[21]
Lola-Luz T, Hennequart F, Gaffney M. Effect on yield, total phenolic, total flavonoid and total isothiocyanate content of two broccoli cultivars (Brassica oleraceae var italica) following the application of a commercial brown seaweed extract (Ascophyllum nodosum). Agric Food Sci 2014; 23(1): 28-37.
[http://dx.doi.org/10.23986/afsci.8832]
[22]
Peterson J, Dwyer J, Jacques P, Rand W, Prior R, Chui K. Tea variety and brewing techniques influence flavonoid content of black tea. J Food Compos Anal 2004; 17(3-4): 397-405.
[http://dx.doi.org/10.1016/j.jfca.2004.03.022]
[23]
Inocencio C, Rivera D, Alcaraz F, Tomás-Barberán FA. Flavonoid content of commercial capers (Capparis spinosa, C. sicula and C. orientalis) produced in mediterranean countries. Eur Food Res Technol 2000; 212(1): 70-4.
[http://dx.doi.org/10.1007/s002170000220]
[24]
D’Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R. Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita 2007; 43(4): 348-61.
[PMID: 18209268]
[25]
Walle T, Otake Y, Walle UK, Wilson FA. Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. J Nutr 2000; 130(11): 2658-61.
[http://dx.doi.org/10.1093/jn/130.11.2658]
[26]
Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005; 81(1): 230S-42S.
[http://dx.doi.org/10.1093/ajcn/81.1.230S] [PMID: 15640486]
[27]
Egert S, Wolffram S, Bosy-Westphal A, et al. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 2008; 138(9): 1615-21.
[http://dx.doi.org/10.1093/jn/138.9.1615] [PMID: 18716159]
[28]
Hollman PCH, Katan MB. Dietary flavonoids: Intake, health effects and bioavailability. Food Chem Toxicol 1999; 37(9-10): 937-42.
[http://dx.doi.org/10.1016/S0278-6915(99)00079-4] [PMID: 10541448]
[29]
Barve A, Chen C, Hebbar V, Desiderio J, Saw CL, Kong AN. Metabolism, bioavailability, and tissue distribution of quercetin and its biologically active metabolites in the rat model. J Pharmacol Exp Ther 2009; 328(2): 539-50.
[30]
Hollman PC. Absorption, bioavailability, and metabolism of flavonoids. Pharmacol Ther 2004; 105(3): 203-15.
[31]
Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 1995; 33(12): 1061-80.
[http://dx.doi.org/10.1016/0278-6915(95)00077-1] [PMID: 8847003]
[32]
Larson A, Witman MAH, Guo Y, et al. Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: nitric oxide. Nutr Res 2012; 32(8): 557-64.
[http://dx.doi.org/10.1016/j.nutres.2012.06.018] [PMID: 22935338]
[33]
Murakami A, Ashida H, Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett 2008; 269(2): 315-25.
[http://dx.doi.org/10.1016/j.canlet.2008.03.046] [PMID: 18467024]
[34]
Jeong JH, An JY, Kwon YT, Rhee JG, Lee YJ. Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression. J Cell Biochem 2009; 106(1): 73-82.
[http://dx.doi.org/10.1002/jcb.21977] [PMID: 19009557]
[35]
Rogerio AP, Kanashiro A, Fontanari C, et al. Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm Res 2007; 56(10): 402-8.
[http://dx.doi.org/10.1007/s00011-007-7005-6] [PMID: 18026696]
[36]
Davis JM, Murphy EA, Carmichael MD, Davis B. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 2009; 296(4): R1071-7.
[http://dx.doi.org/10.1152/ajpregu.90925.2008] [PMID: 19211721]
[37]
Walle T. Absorption and metabolism of flavonoids. Free Radic Biol Med 2004; 36(7): 829-37.
[http://dx.doi.org/10.1016/j.freeradbiomed.2004.01.002] [PMID: 15019968]
[38]
Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 2007; 45(11): 2179-205.
[http://dx.doi.org/10.1016/j.fct.2007.05.015] [PMID: 17698276]
[39]
Shu Y, Liu Y, Li L, et al. Antibacterial activity of quercetin on oral infectious pathogens. Afr J Microbiol Res 2011; 5: 5358-61.
[40]
Parasuraman S, Anand David AV, Arulmoli R. Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacogn Rev 2016; 10(20): 84-9.
[http://dx.doi.org/10.4103/0973-7847.194044] [PMID: 28082789]
[41]
Oliveira VM, Carraro E, Auler ME, Khalil NM. Quercetin and rutin as potential agents antifungal against Cryptococcus spp. Braz J Biol 2016; 76(4): 1029-34.
[http://dx.doi.org/10.1590/1519-6984.07415] [PMID: 27166572]
[42]
Osonga FJ, Akgul A, Miller RM, et al. Antimicrobial activity of a new class of phosphorylated and modified flavonoids. ACS Omega 2019; 4(7): 12865-71.
[http://dx.doi.org/10.1021/acsomega.9b00077] [PMID: 31460413]
[43]
Hooda H, Singh P, Bajpai S. Effect of quercetin impregnated silver nanoparticle on growth of some clinical pathogens. Mater Today Proc 2020; 31: 625-30.
[http://dx.doi.org/10.1016/j.matpr.2020.03.530]
[44]
Wang S, Yao J, Zhou B, et al. Bacteriostatic effect of quercetin as an antibiotic alternative in vivo and its antibacterial mechanism in vitro. J Food Prot 2018; 81(1): 68-78.
[http://dx.doi.org/10.4315/0362-028X.JFP-17-214] [PMID: 29271686]
[45]
Yin J, Peng X, Lin J, et al. Quercetin ameliorates Aspergillus fumigatus keratitis by inhibiting fungal growth, toll-like receptors and inflammatory cytokines. Int Immunopharmacol 2021; 93: 107435.
[http://dx.doi.org/10.1016/j.intimp.2021.107435] [PMID: 33550031]
[46]
Singh BN, Upreti DK, Singh BR, et al. Quercetin sensitizes fluconazole-resistant Candida albicans to induce apoptotic cell death by modulating quorum sensing. Antimicrob Agents Chemother 2015; 59(4): 2153-68.
[http://dx.doi.org/10.1128/AAC.03599-14] [PMID: 25645848]
[47]
Gao M, Wang H, Zhu L. Quercetin assists fluconazole to inhibit biofilm formations of fluconazole-resistant Candida albicans in in vitro and in vivo antifungal managements of vulvovaginal candidiasis. Cell Physiol Biochem 2016; 40(3-4): 727-42.
[http://dx.doi.org/10.1159/000453134] [PMID: 27915337]
[48]
Kuo SM. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 1996; 110(1-2): 41-8.
[http://dx.doi.org/10.1016/S0304-3835(96)04458-8] [PMID: 9018079]
[49]
Srinivasan M, Sudheer AR, Menon VP. Ferulic acid: Therapeutic potential through its antioxidant property. J Clin Biochem Nutr 2007; 40(2): 92-100.
[http://dx.doi.org/10.3164/jcbn.40.92] [PMID: 18188410]
[50]
Choi JA, Kim JY, Lee JY, et al. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int J Oncol 2001; 19(4): 837-44.
[http://dx.doi.org/10.3892/ijo.19.4.837] [PMID: 11562764]
[51]
Sikora E, Cieślik M, Bukowska B. Quercetin induces human colon cancer cells apoptosis and inhibits proliferation of these cells in culture. Cell Mol Biol Lett 2008; 13(2): 312-24.
[52]
Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C. Potential anticancer properties and mechanisms of action of quercetin. Anticancer Res 2013; 33(9): 3543-8.
[53]
Kale A, Gawande S, Kotwal S. Cancer phytotherapeutics: Role for flavonoids at the cellular level. Phytother Res 2008; 22(5): 567-77.
[http://dx.doi.org/10.1002/ptr.2283] [PMID: 18398903]
[54]
Nair HK, Rao KV, Aalinkeel R, Mahajan S. Inhibition of prostate cancer cells by curcumin, quercetin and β-phenylethyl isothiocyanate. J Urol 2004; 171(4): 1650-4.
[55]
Packer L, Smith JR. Extension of the lifespan of cultured normal human diploid cells by vitamin E. Proc Natl Acad Sci USA 1974; 71(12): 4763-7.
[http://dx.doi.org/10.1073/pnas.71.12.4763] [PMID: 4531015]
[56]
Rattan SIS, Clark BFC. Kinetin delays the onset of ageing characteristics in human fibroblasts. Biochem Biophys Res Commun 1994; 201(2): 665-72.
[http://dx.doi.org/10.1006/bbrc.1994.1752] [PMID: 8003000]
[57]
McFarland GA, Holliday R. Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res 1994; 212(2): 167-75.
[http://dx.doi.org/10.1006/excr.1994.1132] [PMID: 8187813]
[58]
Svendsen L, Rattan SIS, Clark BFC. Testing garlic for possible anti-ageing effects on long-term growth characteristics, morphology and macromolecular synthesis of human fibroblasts in culture. J Ethnopharmacol 1994; 43(2): 125-33.
[http://dx.doi.org/10.1016/0378-8741(94)90009-4] [PMID: 7526077]
[59]
Trougakos IP, Chondrogianni N, Pimenidou A, Katsiki M, Tzavelas C, Gonos ES. Slowing down cellular ageing in vitro. Modulating ageing and longevity Rattan SI, Ed. Dordrecht: Kluwer Academic Publishers 2003; pp. 65-83.
[60]
Chondrogianni N, Kapeta S, Chinou I, et al. Anti-ageing and rejuvenating effects of quercetin. Exp Gerontol 2010; 45(10): 763-1.
[http://dx.doi.org/10.1016/j.exger.2010.07.001]
[61]
Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles’ heel of senescent cells: From transcriptome to senolytic drugs. Aging Cell 2015; 14(4): 644-58.
[http://dx.doi.org/10.1111/acel.12344] [PMID: 25754370]
[62]
Kirkland JL. Inflammation and cellular senescence: Potential contribution to chronic diseases and disabilities with aging. Public Policy Aging Rep 2013; 23(4): 12-5.
[http://dx.doi.org/10.1093/ppar/23.4.12]
[63]
Kirkland JL, Tchkonia T. Clinical strategies and animal models for developing senolytic agents. Exp Gerontol 2015; 68: 19-25.
[http://dx.doi.org/10.1016/j.exger.2014.10.012]
[64]
Shaik YB, Castellani ML, Perrella A, et al. Role of quercetin (a natural herbal compound) in allergy and inflammation. J Biol Regul Homeost Agents 2006; 20(3-4): 47-52.
[PMID: 18187018]
[65]
Chirumbolo S. Quercetin as a potential anti-allergic drug: Which perspectives? Iran J Allergy Asthma Immunol 2011; 10(2): 139-40.
[PMID: 21625024]
[66]
Matsuno H, Nakamura H, Katayama K, et al. Effects of an oral administration of glucosamine-chondroitin-quercetin glucoside on the synovial fluid properties in patients with osteoarthritis and rheumatoid arthritis. Biosci Biotechnol Biochem 2009; 73(2): 288-92.
[http://dx.doi.org/10.1271/bbb.80418] [PMID: 19202302]
[67]
Knekt P, Kumpulainen J, Järvinen R, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002; 76(3): 560-8.
[http://dx.doi.org/10.1093/ajcn/76.3.560] [PMID: 12198000]
[68]
Hirano T, Kawai M, Arimitsu J, et al. Preventative effect of a flavonoid, enzymatically modified isoquercitrin on ocular symptoms of Japanese cedar pollinosis. Allergol Int 2009; 58(3): 373-82.
[http://dx.doi.org/10.2332/allergolint.08-OA-0070] [PMID: 19454839]
[69]
Anjaneyulu M, Chopra K, Kaur I. Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. J Med Food 2003; 6(4): 391-5.
[http://dx.doi.org/10.1089/109662003772519976] [PMID: 14977450]
[70]
Bhutada P, Mundhada Y, Bansod K, et al. Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34(6): 955-60.
[http://dx.doi.org/10.1016/j.pnpbp.2010.04.025] [PMID: 20447436]
[71]
Priprem A, Watanatorn J, Sutthiparinyanont S, Phachonpai W, Muchimapura S. Anxiety and cognitive effects of quercetin liposomes in rats. Nanomedicine 2008; 4(1): 70-8.
[http://dx.doi.org/10.1016/j.nano.2007.12.001] [PMID: 18249157]
[72]
Adewole SO, Caxton-Martins EA, Ojewole JA. Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocin-treated diabetic rats. Afr J Tradit Complement Altern Med 2006; 4(1): 64-74.
[PMID: 20162074]
[73]
Holzmann I, da Silva LM, Corrêa da Silva JA, Steimbach VMB, de Souza MM. Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways. Pharmacol Biochem Behav 2015; 136: 55-63.
[http://dx.doi.org/10.1016/j.pbb.2015.07.003] [PMID: 26196245]
[74]
Joshi D, Naidu PS, Singh A, Kulkarni SK. Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions. J Med Food 2005; 8(3): 392-6.
[http://dx.doi.org/10.1089/jmf.2005.8.392] [PMID: 16176153]
[75]
Dixon Clarke SE, Ramsay RR. Dietary inhibitors of monoamine oxidase A. J Neural Transm (Vienna) 2011; 118(7): 1031-41.
[http://dx.doi.org/10.1007/s00702-010-0537-x] [PMID: 21190052]
[76]
Kawabata K, Kawai Y, Terao J. Suppressive effect of quercetin on acute stress-induced hypothalamic-pituitary-adrenal axis response in Wistar rats. J Nutr Biochem 2010; 21(5): 374-80.
[http://dx.doi.org/10.1016/j.jnutbio.2009.01.008] [PMID: 19423323]
[77]
Nair VD, Elias G. Quercetin as an inhibitor of the cytochrome P450 enzyme CYP2D6. Phytother Res 2010; 24(11): 1643-6.
[78]
Duan Z, Di P, Zhou W, Liu J, Liu X. Quercetin enhances the anti-tumor effect of doxorubicin in human breast cancer cells via inhibition of autophagy. PLoS One 2012; 7(12): e51764.
[79]
Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in drug metabolism and chemical toxicity. Environ Health Perspect 2006; 114(1): 1-11.
[80]
Hesse LM, Lown KS. The influence of genetic variability on drug metabolism: Pharmacogenetics in the era of personalized medicine. Pharmacol Ther 2003; 99(3): 211-28.
[81]
Murray M, Phelan D. Phase I and Phase II drug metabolism. In: Fundamentals of Drug Metabolism and Drug Interactions. 2011; pp. 223-45.
[82]
Kupfermann I. The pharmacological basis of drug metabolism: Phase I and Phase II. In: Casarett & Doull’s Toxicology: The Basic Science of Poisons. Klaassen CD, ed. 5th ed. New York (NY): McGraw-Hill 2001; pp. 565-610.
[83]
Coulter ID, Pruett SB. Liver disease and neurotransmitter regulation: Implications for drug dependence. J Hepatol 1996; 25(3): 287-93.
[84]
Smith TS, McKinney J. The influence of liver function on the pharmacokinetics of psychoactive drugs. J Clin Psychiatry 2005; 66(2): 231-41.
[85]
Nam JS, Sharma AR, Nguyen LT, Chakraborty C, Sharma G, Lee SS. Application of bioactive quercetin in oncotherapy: From nutrition to nanomedicine. Molecules 2016; 21(1): 108.
[http://dx.doi.org/10.3390/molecules21010108]
[86]
Bertino JS. The effect of liver disease on drug metabolism and response. Liver Transpl 2003; 9(5): 511-7.
[87]
He X, Xu H. Interaction between liver and gastrointestinal tract in drug metabolism. Clin Pharmacokinet 2012; 51(6): 355-69.
[88]
Okamoto T. Safety of quercetin for clinical application (Review). Int J Mol Med 2005; 16(2): 275-8.
[http://dx.doi.org/10.3892/ijmm.16.2.275] [PMID: 16012761]
[89]
Utesch D, Feige K, Dasenbrock J, et al. Evaluation of the potential in vivo genotoxicity of quercetin. Mutat Res Genet Toxicol Environ Mutagen 2008; 654(1): 38-44.
[http://dx.doi.org/10.1016/j.mrgentox.2008.04.008] [PMID: 18556240]
[90]
Morino K, Matsukura N, Kawachi T, Ohgaki H, Sugimura T, Hirono I. Carcinogenicity test of quercetin and rutin in golden hamsters by oral administration. Carcinogenesis 1982; 3(1): 93-7.
[http://dx.doi.org/10.1093/carcin/3.1.93] [PMID: 7067042]
[91]
Pérez-Pastén R, Martínez-Galero E, Chamorro-Cevallos G. Quercetin and naringenin reduce abnormal development of mouse embryos produced by hydroxyurea. J Pharm Pharmacol 2010; 62(8): 1003-9.
[http://dx.doi.org/10.1111/j.2042-7158.2010.01118.x] [PMID: 20663034]
[92]
Vanhees K, de Bock L, Godschalk RWL, van Schooten FJ, van Waalwijk van Doorn-Khosrovani SB. Prenatal exposure to flavonoids: Implication for cancer risk. Toxicol Sci 2011; 120(1): 59-67.
[http://dx.doi.org/10.1093/toxsci/kfq388] [PMID: 21177254]
[93]
Cantero G, Campanella C, Mateos S, Cortés F. Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin. Mutagenesis 2006; 21(5): 321-5.
[http://dx.doi.org/10.1093/mutage/gel033] [PMID: 16950806]
[94]
Sudan S, Rupasinghe HV. Antiproliferative activity of long chain acylated esters of quercetin-3-O-glucoside in hepatocellular carcinoma HepG2 cells. Exp Biol Med (Maywood) 2015; 240(11): 1452-64.
[http://dx.doi.org/10.1177/1535370215570828]
[95]
Hossion AML, Zamami Y, Kandahary RK, et al. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents. J Med Chem 2011; 54(11): 3686-703.
[http://dx.doi.org/10.1021/jm200010x] [PMID: 21534606]

Rights & Permissions Print Cite
Article Metrics
Pdf icon 34
Html icon 2
Find your institution